Trousdale M D, Nesburn A B
Invest Ophthalmol Vis Sci. 1984 Apr;25(4):480-3.
Recombinant human interferon (IFN) alpha A and alpha D combined with 1% trifluridine ophthalmic solution gave beneficial results when applied topically at a dose of 1 x 10(6) U per eye four times a day commencing 4 hr after eyes were inoculated with herpes simplex virus (HSV-1). Acute herpetic keratitis was suppressed by trifluridine alone and the combined therapies, but the high-titered interferon preparations, alone, had little effect. Duration of HSV-1 shedding into tear film during topical treatment for acute herpetic keratitis was reduced slightly by combined therapy with either IFN alpha A or IFN alpha D with trifluridine.
重组人干扰素αA和αD与1%三氟尿苷滴眼液联合使用时,在接种单纯疱疹病毒(HSV-1)4小时后开始,以每只眼1×10⁶单位的剂量每天局部应用4次,取得了有益的效果。单独使用三氟尿苷以及联合治疗均能抑制急性疱疹性角膜炎,但单独使用高滴度干扰素制剂几乎没有效果。在急性疱疹性角膜炎局部治疗期间,干扰素αA或干扰素αD与三氟尿苷联合治疗可使泪膜中HSV-1脱落的持续时间略有缩短。